Table 3.
Variablesb | Multivariable-adjustedc | Multivariable-adjustedd | ||
---|---|---|---|---|
Odds ratios (95% CI) | p value | Odds ratios (95% CI) | p value | |
Estimated glomerular filtration rate (17.4 ml/min/1.73 m2) | 0.73 (0.57–0.93) | 0.01 | 0.80 (0.61–1.04) | 0.10 |
Log (24-hour urine albumin, 0.53 g/24 hours) | 1.44 (1.11–1.87) | 0.006 | 1.21 (0.90–1.63) | 0.21 |
Cystatin C (0.66 mg/L) | 1.24 (1.01–1.53) | 0.04 | 1.16 (0.92–1.45) | 0.21 |
Calcium (0.52 mg/dL) | 0.82 (0.63–1.06) | 0.13 | 0.89 (0.67–1.18) | 0.43 |
Phosphate (0.68 mg/dL) | 1.59 (1.22–2.08) | <0.001 | 1.51 (1.13–2.01) | 0.005 |
Log (fibroblast growth factor-23, 0.82 RU/mL) | 1.38 (1.12–1.71) | 0.003 | 1.32 (1.05–1.67) | 0.02 |
Log (total parathyroid hormone, 0.67 pg/mL) | 1.44 (1.13–1.84) | 0.003 | 1.34 (1.03–1.74) | 0.03 |
Alkaline phosphatase (31.2 U/L) | 0.99 (0.79–1.24) | 0.93 | 0.85 (0.67–1.09) | 0.20 |
Hemoglobin A1c (1.37%) | 1.39 (1.09–1.78) | 0.009 | 1.22 (0.87–1.72) | 0.25 |
Log (HOMA-insulin resistance, 0.62) | 1.24 (0.98–1.58) | 0.08 | 1.06 (0.79–1.43) | 0.70 |
Uric acid (1.84 mg/dL) | 1.22 (0.95–1.57) | 0.11 | 1.10 (0.84–1.44) | 0.49 |
Homocysteine (4.93 μmol/L) | 1.27 (0.97–1.66) | 0.09 | 1.24 (0.93–1.65) | 0.15 |
Fibrinogen (1.10 mg/dL) | 1.46 (1.14–1.87) | 0.003 | 1.32 (1.01–1.73) | 0.04 |
Log (high sensitive C-reactive protein, 0.80 mg/L) | 1.16 (0.91–1.48) | 0.23 | 1.04 (0.80–1.36) | 0.75 |
Log (interleukin-6, 0.57 pg/mL) | 1.63 (1.22–2.17) | <0.001 | 1.46 (1.08–1.99) | 0.02 |
Log (tumor necrosis factor-α, 0.52 mg/dL) | 1.39 (1.09–1.77) | 0.009 | 1.28 (0.99–1.66) | 0.06 |
Incident coronary artery calcification was defined as any increase in CAC from the baseline to follow-up visit.
One standard deviation increase.
Adjusted for age, sex, race/ethnicity, clinical site, and follow-up time between CT scans.
Adjusted for age, sex, race/ethnicity, clinical site, follow-up time between CT scans, total cholesterol, HDL cholesterol, systolic BP, use of antihypertensive medications, diabetes, current smoking, history of CVD, use of statin medications, and physical activity.